AMIT SONI

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Hematology-Oncology ORANGE, CA NPI 1659539211

General Payments — all program years on this page

$71,357.21

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 98
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $11,509.64 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
BioMarin Pharmaceutical Inc. $9,741.2410
CSL Behring $1,680.001
VERTEX PHARMACEUTICALS INCORPORATED $57.432
Alexion Pharmaceuticals, Inc. $30.971

By program year

Program yearAmountRecords
2018 $16,753.5323
2019 $20,222.7134
2020 $11,731.7210
2021 $8,949.059
2022 $2,109.714
2023 $80.854
2024 $11,509.6414

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1093936184 Alexion Pharmaceuticals, Inc. $30.97 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105911876 VERTEX PHARMACEUTICALS INCORPORATED $29.75 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105921481 VERTEX PHARMACEUTICALS INCORPORATED $27.68 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127057527 BioMarin Pharmaceutical Inc. $1,207.88 09/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1127059515 BioMarin Pharmaceutical Inc. $77.00 09/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1127059525 BioMarin Pharmaceutical Inc. $3,840.00 09/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1127059533 BioMarin Pharmaceutical Inc. $503.96 09/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1127059547 BioMarin Pharmaceutical Inc. $303.97 09/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1127059567 BioMarin Pharmaceutical Inc. $107.23 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127059581 BioMarin Pharmaceutical Inc. $124.79 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127059595 BioMarin Pharmaceutical Inc. $86.61 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127060697 BioMarin Pharmaceutical Inc. $9.80 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127063048 BioMarin Pharmaceutical Inc. $3,480.00 11/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1134606211 CSL Behring $1,680.00 10/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.